Join Dr. Cusi in this CME program to learn more about current guideline recommendations to identify and diagnose patients at risk of developing NASH, how to assess the risk of NASH progression and liver-related events, as well as recommendations for current and emerging therapies to effectively manage these patients.
Key learning objectives
- Know the recent clinical guideline recommendations on diagnosis of liver fibrosis
- Know the recent evidence and recommendations regarding new and emerging therapies
- Understand the implementation of noninvasive tests for liver fibrosis in clinical practice